These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604 [TBL] [Abstract][Full Text] [Related]
10. Combined assessment of clinical and pathological prognostic factors for deciding treatment strategies for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic submucosal dissection. Shimada T; Hatta W; Takahashi S; Koike T; Ohira T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Nakamura J; Matsumoto T; Iijima K; Fukuda S; Masamune A; Ito K; Dig Endosc; 2022 Nov; 34(7):1382-1391. PubMed ID: 35702926 [TBL] [Abstract][Full Text] [Related]
11. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study. Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa. Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion. Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349 [TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review. Tsou YK; Lee CH; Le PH; Chen BH Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study. Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830 [TBL] [Abstract][Full Text] [Related]
17. Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma. Takahashi K; Hashimoto S; Mizuno KI; Kobayashi T; Tominaga K; Sato H; Kohisa J; Ikarashi S; Hayashi K; Takeuchi M; Yokoyama J; Kawai H; Sato Y; Kobayashi M; Terai S Endoscopy; 2018 Jul; 50(7):662-670. PubMed ID: 29272907 [TBL] [Abstract][Full Text] [Related]
18. Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis. Flor de Lima M; Castro B; Rodríguez-Carrasco M; Libânio D; Pimentel-Nunes P; Sousa O; Dinis-Ribeiro M Scand J Gastroenterol; 2022 May; 57(5):525-533. PubMed ID: 34986068 [TBL] [Abstract][Full Text] [Related]
19. Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studies. Jansen M; Schölvinck DW; Kushima R; Sekine S; Weusten BL; Wang GQ; Fleischer DE; Yoshinaga S; Dawsey SM; Meijer SL; Bergman JJ; Oda I Gastrointest Endosc; 2014 Dec; 80(6):995-1002. PubMed ID: 25434658 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of endoscopic resection for intramucosal esophageal squamous cell cancer: a secondary analysis of the Japan Esophageal Cohort study. Oda I; Shimizu Y; Yoshio T; Katada C; Yokoyama T; Yano T; Suzuki H; Abiko S; Takemura K; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Katagiri A; Yamanouchi T; Matsuo Y; Kawakubo H; Kobayashi N; Shimoda T; Ochiai A; Ishikawa H; Yokoyama A; Muto M Endoscopy; 2020 Nov; 52(11):967-975. PubMed ID: 32583396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]